DTC Report: DTC Gets Smart
DTC Report: 10 Riskiest DTC Ads Ever
Rare Diseases: Orphans in Danger
Therapeutic Focus 2014: Respiratory
Headliner: Pharma's type "A" exec—and mentor
Non-Personal Promotion: A New Era in E-Sampling
Read the 2014 Game Changers digital edition
Skill Sets Live: Content Marketing for Healthcare
The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.
The newly formed group will be known as Calcium with Steve Michaelson, formerly of Rosetta Wishbone, at the helm.
Medscape's survey of over 24,000 physicians found that a paycheck is not necessarily linked to a physician's professional satisfaction.
Centers for Disease Control data shows that diabetes complications including heart attack and amputation fell in the twenty years between 1990 and 2010. The bad news: the number of diagnosed diabetes patients tripled during that same time period.
Nine things CMOs should consider when desiring to engage consumers who no longer want to give their attention to boring and scripted product descriptions.
A District Court says Massachusetts cannot ban opioid painkiller Zohydro.
Ranbaxy may be on the blocks, but it has a hold on the right to produce generics of the Novartis heart medication Diovan. Only problem: it can't, and that is good news for Novartis.
Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.
Click on the image above to see a gallery of images from the 2013 MM&M Awards dinner
The new MM&M e-book, "Oncology Marketing," is designed to serve as a companion for those in the business of communicating cancer products to all three stakeholders. It's packed with analysis, advice, insights and commentary to help navigate the terrain. Click here to access it.